About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: February 2018
Weekly Roundup 2.9.18
February. When the inconvenient bursts of weird precipitation, the cold and the dark starts really getting on your nerves. They made it the shortest month for a reason. Facing the prospect of yet another government shutdown, it appeared that at … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 2.9.18
FDA’s 2018 Strategic Policy Roadmap, Part 1
In January, FDA’s Commissioner announced the release of “Health Innovation, Safer Families: FDA’s 2018 Strategic Policy Roadmap” that provides a detailed overview of priorities for the agency within a relatively short timeframe. FDA and the various centers that make up … Continue reading
Posted in FDA Policy
Comments Off on FDA’s 2018 Strategic Policy Roadmap, Part 1
Weekly Roundup 2.2.18
Groundhog Day is happening today to bring us the valuable insight related to the length of winter and the beginning of Spring. Exciting, but not as thrilling in my mind as the re-establishment of Daylight Saving Time when the hours … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 2.2.18